BGM Group Ltd.
$0.36
▲
10.86%
2026-04-21 05:38:01
www.bgmgroupltd.com
NCM: BGM
Explore BGM Group Ltd. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$59.42 M
Current Price
$0.36
52W High / Low
$17.17 / $0.27
Stock P/E
—
Book Value
$1.85
Dividend Yield
—
ROCE
-0.81%
ROE
-3.37%
Face Value
—
EPS
$-0.29
Exp Qtr EPS
—
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
—
Beta
—
Debt / Equity
0.97
Current Ratio
3.39
Quick Ratio
2.82
Forward P/E
—
Price / Sales
—
Enterprise Value
$22.24 M
EV / EBITDA
—
EV / Revenue
—
Rating
None
Target Price
—
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Esperion Therapeutics, Inc. | $2.02 | — | $510.15 M | — | 36.51% | 6.57% | $4.17 / $0.69 | $-1.23 |
| 2. | BioCryst Pharmaceuticals, Inc. | $9.19 | 8.7 | $2.3 B | — | 107.2% | -88.68% | $11.31 / $6 | $-0.56 |
| 3. | Aquestive Therapeutics, Inc. | $4.24 | — | $527.23 M | — | -62.98% | 178.61% | $7.55 / $2.12 | $-0.28 |
| 4. | Ironwood Pharmaceuticals, Inc. | $4.42 | 29.94 | $719.09 M | — | 76.78% | -8.53% | $5.78 / $0.53 | $-1.61 |
| 5. | BioAge Labs, Inc. | $18.8 | — | $820.58 M | — | -33.77% | -27.09% | $24 / $3.63 | $7.28 |
| 6. | Canopy Growth Corporation | $1.2 | — | $709.79 M | — | -8.06% | -48.5% | $3.28 / $1.18 | $1.49 |
| 7. | Cronos Group Inc. | $2.76 | — | $1.4 B | — | -1.7% | -0.26% | $4.66 / $2.35 | $2.87 |
Quarterly Results
Figures shown in M / B
| Sales |
|---|
| Operating Profit |
| Net Profit |
| EPS in Rs |
Profit & Loss
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Sales | 25.1 M | 46.47 M | 64.86 M | 57.1 M |
| Operating Profit | -0.36 M | -2.42 M | 2.52 M | 2.95 M |
| Net Profit | -1.44 M | -7.78 M | 1.08 M | 3.15 M |
| EPS in Rs | -0.01 | -0.04 | 0.01 | 0.02 |
Balance Sheet
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Total Assets | 53 M | 51.26 M | 64.53 M | 75.35 M |
| Total Liabilities | 8.91 M | 6.91 M | 9.56 M | 18.68 M |
| Equity | 42.74 M | 42.79 M | 53.05 M | 54.86 M |
| Current Assets | 29.77 M | 34.51 M | 30.03 M | 40.37 M |
| Current Liabilities | 8.78 M | 6.66 M | 9.18 M | 18.17 M |
Cash Flow
Last available yearly cash flow history
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Operating CF | 0.54 M | 0.31 M | 12.65 M | 0.35 M |
| Investing CF | 0.98 M | -4.74 M | -3.26 M | -24.2 M |
| Financing CF | -0.49 M | -2.92 M | -5.94 M | 23.99 M |
| Free CF | -3.39 M | -3.4 M | 9.4 M | -3.15 M |
| Capex | -3.93 M | -3.71 M | -3.26 M | -3.49 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -45.99% | -28.35% | 13.58% | — |
| Earnings Growth % | 81.46% | -822.64% | -65.85% | — |
| Profit Margin % | -5.75% | -16.74% | 1.66% | 5.52% |
| Operating Margin % | -1.42% | -5.2% | 3.88% | 5.17% |
| Gross Margin % | 16.39% | 3.77% | 9.6% | 9.87% |
| EBITDA Margin % | 3.51% | -2.74% | 5.77% | 7.27% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2023-02-27 | $0.25 |
Stock Splits
| Date | Split |
|---|---|
| 2024-06-21 | 1:0.2 |